Brief: Genxone Signs Validation Deal For New PCR SARS-CoV-2 Test With South Korean Seegene
11/05/2021 12:33
May 11 (Reuters) - Genxone SA GX1.WA :
* SAYS SIGNS VALIDATION DEAL FOR NEW REAL TIME PCR
SARS-COV-2 TEST
WITH SOUTH KOREAN SEEGENE
Source text for Eikon: ID:nEM2NpsC8a
Further company coverage: GX1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Genxone SA
See all newsBrief: Genxone Q2 Net Loss 0.3 Million Zlotys
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys